Skip to main content
. 2007 Feb 13;96(5):692–700. doi: 10.1038/sj.bjc.6603568

Figure 5.

Figure 5

Comparison of tumour microvessel fractal dimension and diameter in control and rhEPO-treated rats. (A, B) Examples of CD31-stained microvessels in the tumour core of control and rhEPO-treated animals. Bar, 25 μm. (C) Microvessel fractal dimension in the tumour core and rim in control and rhEPO-treated animals. Columns, mean; bars, s.e.; *P=0.006. (D) Microvessel diameter in the tumour core and rim in control and rhEPO-treated animals. Columns, mean; bars, s.e.; *P<0.001; **P=0.07.